Daily non-political popular news in brief.
NIAID scientists identify human protein that helps chickenpox and shingles virus spread
10-19-2006 · EurekAlert!A team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has identified a human protein that helps varicella-zoster virus, the cause of chickenpox and shingles, spread from cell to cell within the body.
Read more »
Keywords: niaid, scientists, identify, human, protein, chickenpox, shingles, virus, spread, scientist, shingle, viru
« Previous | Next »
Similar news on "NIAID scientists identify human protein that helps chickenpox and shingles virus spread":
- NIAID scientists identify new cellular receptor for HIV
02-10-2008 · EurekAlert!
A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Similar news · Read more »
- UF scientists identify cancer virus' genetic targets
05-10-2007 · EurekAlert!
University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi's sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people's skin.
Similar news · Read more »
- Jefferson scientists identify protein key to breast cancer spread, potential new drug target
04-09-2007 · EurekAlert!
Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
Similar news · Read more »
- NIAID DNA vaccine for H5N1 avian influenza enters human trial
01-03-2007 · EurekAlert!
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.
Similar news · Read more »
- Study of sugars on cell surface identifies key factor in flu infection
01-06-2008 · EurekAlert!
Scientists have identified a new factor critical for influenza viruses to infect the human upper respiratory tract -- a necessary step for sustaining spread between people. The research offers additional insight into how the H5N1 avian flu virus currently circulating in birds would have to change in order to gain a foothold in human populations.
Similar news · Read more »
- Virtual human in HIV drug simulation
01-29-2008 · EurekAlert!
The combined supercomputing power of the UK and US 'national grids' has enabled UCL scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method -- an early example of the Virtual Physiological Human in action -- could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.
Similar news · Read more »
- Brown scientists map structure of DNA-doctoring protein complex
12-06-2006 · EurekAlert!
Mobile DNA, which inserts foreign genes into target cells, is a powerful force in the march of evolution and the spread of disease. Working with the lambda virus and E. coli bacteria, Brown University biologists have solved the structure of a six-protein complex critical to performing this gene-grafting surgery. The technique they developed could be used to reveal the structure of other critical protein complexes, landing the work on the cover of Molecular Cell.
Similar news · Read more »
- Casting the molecular net
06-14-2007 · EurekAlert!
Scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, European Molecular Biology Laboratory, and Massachusetts Institute of Technology have created a new computational method called NetworKIN. This method uses biological networks to better identify relationships between molecules. In a cover story featured in the June 29, 2007, edition of the journal Cell, the scientists report insights into the regulation of protein networks that will ultimately help to target human disease.
Similar news · Read more »
- Scientists unveil piece of HIV protein that may be key to AIDS vaccine development
02-14-2007 · EurekAlert!
In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the NIAID have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody. Unlike much of the constantly mutating virus, this protein component is stable and -- more importantly, say the researchers -- appears vulnerable to attack from this specific antibody, known as b12, that can broadly neutralize HIV.
Similar news · Read more »
- Penn study suggests new model for testing and discovery of anti-HIV drugs
02-08-2007 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine are the first to show that a mouse protein, whose human equivalent is related to defense against HIV-1, inhibits the infection and spread of a mouse tumor virus. The study provides a new model for the discovery and evaluation of anti-HIV drugs.
Similar news · Read more »
